Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-57
Closed -$1K 298
2019
Q2
$1K Hold
57
﹤0.01% 306
2019
Q1
$1K Hold
57
﹤0.01% 303
2018
Q4
$858 Hold
57
﹤0.01% 322
2018
Q3
$2.24K Hold
57
﹤0.01% 337
2018
Q2
$2.8K Hold
57
﹤0.01% 301
2018
Q1
$3.41K Hold
57
﹤0.01% 303
2017
Q4
$4.49K Hold
57
﹤0.01% 265
2017
Q3
$4.79K Hold
57
﹤0.01% 292
2017
Q2
$3.73K Hold
57
﹤0.01% 316
2017
Q1
$4.14K Sell
57
-446
-89% -$29.3K ﹤0.01% 334
2016
Q4
$29.5K Buy
+503
New +$26.6K 0.02% 219

Other funds holding ADNT

West Oak Capital's ADNT Position: Q3 2019 in Review

West Oak Capital sold out of Adient (ADNT) in Q3 2019, closing a stake of 57 shares — an estimated $1K sold.

West Oak Capital first reported a position in ADNT in Q4 2016 and held it in 11 quarters. The position peaked at $29.5K in Q4 2016. 307 funds tracked by Wall St. Rank hold ADNT as of Q3 2019.

  • West Oak Capital reported no remaining Adient position as of Q3 2019 after selling out during the quarter.
  • West Oak Capital sold 57 Adient shares in Q3 2019, an estimated $1K.
  • West Oak Capital first reported a position in Adient in Q4 2016 and held it in 11 quarters.
  • West Oak Capital's Adient position peaked at $29.5K in Q4 2016.
  • 307 funds tracked by Wall St. Rank held Adient as of Q3 2019.

Based on West Oak Capital's 13F filing for Q3 2019, filed 2 Oct 2019.